[Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors]

Insights

Rocky Mountain spotted fever (RMSF) has a high fatality rate in children. Timely doxycycline treatment, avoiding delays, and managing acute renal failure and severe sepsis can improve outcomes for pediatric RMSF patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Clinical Medicine

Background:

  • Rocky Mountain spotted fever (RMSF) poses a significant threat to children's health.
  • Understanding clinical manifestations and mortality predictors is crucial for effective management.

Purpose of the Study:

  • To characterize clinical features of pediatric RMSF.
  • To identify predictors of mortality in hospitalized children with RMSF.

Main Methods:

  • A cross-sectional study was conducted involving 210 pediatric patients diagnosed with RMSF.
  • Data were collected from January 2004 to June 2015 in Sonora, Mexico.
  • Statistical analysis included descriptive statistics and multivariate logistic regression.

Main Results:

  • An increasing trend in RMSF morbidity and mortality was observed.
  • The overall fatality rate was 30%.
  • Key predictors of death included delayed doxycycline treatment (≥ 5 days), acute renal failure, and severe sepsis.

Conclusions:

  • RMSF is associated with high mortality in pediatric populations.
  • Prompt initiation of doxycycline treatment is vital for preventing fatalities.
  • Acute renal failure and severe sepsis are independent predictors of mortality in children with RMSF.
Abstract

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
677
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312